Biostage announced it raised $1.48 Million in an initial filing from an offering of $1.48 Million
08/06/24, 8:14 PM
Location
hollistonMoney raised
$1.48 million
Industry
biotechnology
Company Info
Location
holliston, massachusetts, united states
Additional Info
Biostage, Inc. (OTCQB: formerly BSTG) announced today it has changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and will trade under the OTCQB symbol "HRGN" effective July 20, 2023. Harvard Apparatus Regenerative Technology, Inc., is a clinical stage biotechnology company that is focused on the development of organ replacement therapies using cellular scaffolds and tissue engineering to restore organ function.